Next Article in Journal
Iodine Concentration in Breastmilk and Urine among Lactating Women of Bhaktapur, Nepal
Next Article in Special Issue
Resveratrol and Cardiovascular Diseases
Previous Article in Journal
Moderately Low Magnesium Intake Impairs Growth of Lean Body Mass in Obese-Prone and Obese-Resistant Rats Fed a High-Energy Diet
Previous Article in Special Issue
Wine Resveratrol: From the Ground Up
Article Menu

Export Article

Open AccessReview
Nutrients 2016, 8(5), 254; doi:10.3390/nu8050254

Resveratrol and Myopathy

INSERM UMRS 1124, Université Paris Descartes, Paris 75006, France
*
Author to whom correspondence should be addressed.
Received: 22 February 2016 / Revised: 18 April 2016 / Accepted: 21 April 2016 / Published: 28 April 2016
(This article belongs to the Special Issue Selected Papers from Resveratrol Regional Meeting 2015)
View Full-Text   |   Download PDF [779 KB, uploaded 28 April 2016]   |  

Abstract

Resveratrol is a natural polyphenolic compound produced by plants under various stress conditions. Resveratrol has been reported to exhibit antioxidant, anti-inflammatory, and anti-proliferative properties in mammalian cells and animal models, and might therefore exert pleiotropic beneficial effects in different pathophysiological states. More recently, resveratrol has also been shown to potentially target many mitochondrial metabolic pathways, including fatty acid β-oxidation or oxidative phosphorylation, leading to the up-regulation of the energy metabolism via signaling pathways involving PGC-1α, SIRT1, and/or AMP-kinase, which are not yet fully delineated. Some of resveratrol beneficial effects likely arise from its cellular effects in the skeletal muscle, which, surprisingly, has been given relatively little attention, compared to other target tissues. Here, we review the potential for resveratrol to ameliorate or correct mitochondrial metabolic deficiencies responsible for myopathies, due to inherited fatty acid β-oxidation or to respiratory chain defects, for which no treatment exists to date. We also review recent data supporting therapeutic effects of resveratrol in the Duchenne Muscular Dystrophy, a fatal genetic disease affecting the production of muscle dystrophin, associated to a variety of mitochondrial dysfunctions, which likely contribute to disease pathogenesis. View Full-Text
Keywords: metabolic myopathies; mitochondrial disorders; Duchenne muscular dystrophy; resveratrol metabolic myopathies; mitochondrial disorders; Duchenne muscular dystrophy; resveratrol
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bastin, J.; Djouadi, F. Resveratrol and Myopathy. Nutrients 2016, 8, 254.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top